AMMONIA N 13 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ammonia N 13, and when can generic versions of Ammonia N 13 launch?
Ammonia N 13 is a drug marketed by 3d Imaging Drug, Biomedcl Res Fdn, Brigham Womens Hosp, Cardinal Hlth 414, Central Radiopharm, Decatur, Essential Isotopes, Feinstein, Gen Hosp, Ionetix, Johns Hopkins Univ, Kreitchman Pet Ctr, Mcprf, Methodist, Midwest Medcl, Mips Crf, Ncm Usa Bronx Llc, Nukemed, Petnet, Precision Nuclear, Shertech Labs Llc, Sofie, Ucla Biomedical, Ucsf Rodiopharm, Univ Alahama Birm, Univ Tx Md Anderson, Univ Tx Sw Medctr, Univ Wisconsin, Wa Univ Sch Med, and Wisconsin. and is included in thirty-one NDAs.
The generic ingredient in AMMONIA N 13 is ammonia n-13. There are two drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the ammonia n-13 profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMMONIA N 13?
- What are the global sales for AMMONIA N 13?
- What is Average Wholesale Price for AMMONIA N 13?
Summary for AMMONIA N 13
| US Patents: | 0 |
| Applicants: | 30 |
| NDAs: | 31 |
| Finished Product Suppliers / Packagers: | 20 |
| Raw Ingredient (Bulk) Api Vendors: | 4 |
| Clinical Trials: | 103 |
| Patent Applications: | 829 |
| What excipients (inactive ingredients) are in AMMONIA N 13? | AMMONIA N 13 excipients list |
| DailyMed Link: | AMMONIA N 13 at DailyMed |
Recent Clinical Trials for AMMONIA N 13
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Khyber Medical College, Peshawar | Phase 4 |
| Cairo University | Phase 3 |
| CBmed Ges.m.b.H. | Phase 4 |
Pharmacology for AMMONIA N 13
| Drug Class | Radioactive Diagnostic Agent |
| Mechanism of Action | Radiopharmaceutical Activity |
US Patents and Regulatory Information for AMMONIA N 13
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Univ Tx Sw Medctr | AMMONIA N 13 | ammonia n-13 | INJECTABLE;INTRAVENOUS | 209507-001 | Nov 1, 2019 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Univ Wisconsin | AMMONIA N 13 | ammonia n-13 | INJECTABLE;INTRAVENOUS | 211740-001 | Sep 9, 2020 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| 3d Imaging Drug | AMMONIA N 13 | ammonia n-13 | INJECTABLE;INTRAVENOUS | 203779-001 | Oct 19, 2015 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
